Navigation Links
Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings
Date:1/15/2014

FRANKLIN, Ohio, Jan. 15, 2014 /PRNewswire/ -- A novel wearable injector slightly larger than an Oreo cookie may soon make it easy and painless for patients to self-inject prescription drugs in the large doses required to treat a wide range of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders. 

An emerging biologic drugs market is expected to grow to $220B by 2018, according to analysts.   Many of these drugs will require a new type of injector that does not exist today for self-administration of high volumes and high viscosities.

Mike Hooven, Enable Injections LLC's founder and CEO, will present a new drug delivery technology that addresses these needs to pharmaceutical executives at two meetings this month:

  • PepTalk, a meeting for developers of protein and antibody therapeutics, January 13-17 in Palm Springs, CA
  • Drug Delivery Partnerships, for developers of new and repurposed drugs, January 27-29 in Boca Raton, FL

"Having an injector like this, especially one that decreases pain, opens the door to new pharmaceuticals that wouldn't be possible without this revolutionary device," says Gary Ansel, MD, Associate Medical Director of the OhioHealth Research and Innovation Institute in Columbus.  "We're talking potential for huge cost savings, reduced hospital stays, and increased patient compliance—all at the push of a button."

Currently available for investigational use only, Enable's bolus injector uses standard vials, can automatically mix powdered/liquid vials, and may deliver doses as large as 20cc.  Patients would wear the disposable device under their clothing and comfortably go about their business during the infusion.  

"Enable has a world-class design team that has developed a unique technology to address this exciting new opportunity.  We're looking forward to working with our pharmaceutical partners to introduce these products to market," says Hooven, a medical device veteran who previously founded AtriCure, the first device company to obtain FDA clearance for the surgical treatment of atrial fibrillation. 

About Enable Injections
Enable Injections, LLC develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue.   The system uses a standard vial container closure, and can automatically mix lyophilized solutions.  Founded February 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio.


'/>"/>
SOURCE Enable Injections, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kareo Launches New Solution Center to Enable Private Practice Success
2. Ekahau RTLS Enables Asset and Temperature Tracking in Five VISN-10 Veterans Health Administration Hospitals and Two Clinics
3. Experian Healthcare launches tool to enable providers to identify and help enroll eligible individuals for health insurance exchange (HIX) subsidized programs
4. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
5. NW Bio Receives Regulatory Decision That Will Enable Its Phase III Brain Cancer Trial To Proceed In Germany
6. New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
7. Quantum Materials Tetrapod Quantum Dots Break Kashas Rule: Enhanced Performance Enables Commercialization of Novel Discovery
8. Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
9. Varian Enables HIPAA Compliance and Optimizes Customer Service with the Axeda Machine Cloud
10. Cloud Enables Advances in Medical Imaging Innovation
11. Leica Biosystems and Dell Enable Access to Pathology Images Between China and the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... WAYNE, N.J. , June 16, 2017 Datascope Corp. ... sold by Datascope Corp. for a potential electrical test failure code.     ... PRODUCT PART NUMBER ... CS100 IABP CS300 IABP ... ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
Breaking Medicine Technology:
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Act (BCRA), their proposed healthcare bill to repeal and replace the Affordable Care ... Senate bill would make significant cuts to Medicaid, a public health insurance program ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own ... others prefer to read it, and some people don't like it at all. FindaTopDoc ... what they found: , Erotic literature can give readers a taste of their deepest, ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia Leaders ... leaders from government, business and civil society in 11 countries across the Middle East ... engaging in a transformative exchange of knowledge and ideas with the leading minds in ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Ulster University, ... June, 2017 from 9 am to 3 pm to present to graduate students exciting ... is an original curriculum project led by The Health Improvement Service of the ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, an eastern ... access to asset protection and financial planning services, is teaming up with the ... lives of children with cancer and other chronic diseases. , The For A ...
Breaking Medicine News(10 mins):